SMLF: Small Cap ETF With Superior Risk-Adjusted Return — Positive
SMLF Seeking Alpha — December 31, 2025iShares U.S. Small-Cap Equity Factor ETF delivers diversified small-cap exposure, blending momentum, quality, value, and low volatility factors. SMLF exhibits low company and sector risk, a moderate growth tilt, and a 0.15% expense ratio, outperforming the Russell 2000 since inception. Compared to peers, SMLF boasts low volatility and excellent Sharpe ratio since October 2019, despite trailing AVUV and XSVM in total return.
AB InBev's Latin America Strength Offsets U.S. Beer Weakness — Neutral
BUD Zacks Investment Research — December 31, 2025BUD's Latin America strength offsets U.S. beer softness, delivering EBITDA growth and margin gains despite volume pressure.
SE's Credit Loss Provisions Surge: Is Digital Finance Growth at Risk? — Positive
SE Zacks Investment Research — December 31, 2025Sea Limited's fast-growing digital finance arm is lifting revenues, but soaring credit loss provisions and rising costs are putting pressure on profitability.
IFF Gains From Focus on Growth Despite Low Food Ingredient Volumes — Neutral
IFF Zacks Investment Research — December 31, 2025International Flavors sharpens its portfolio and capital discipline to fuel growth, even as weak Food Ingredients volumes and currency risks pressure margins.
CNA Stock Near 52-Week High: Time to Add It for Better Returns? — Positive
CNA Zacks Investment Research — December 31, 2025CNA Financial is poised to gain from solid retention, favorable renewal premium change and new business growth across Specialty, Commercial and International segments.
AI Demand Lifts Semiconductor Stock; Bullish Bets Build — Positive
TSM Schaeffers Research — December 31, 2025Shares of Taiwan Semiconductor Manufacturing Co (NYSE:TSM) are up 2% to trade at $305.55 at last check, after sector peer Nvidia (NVDA) encouraged the chipmaker to boost production of its H200 AI chips to meet rising demand from China.
Resilient Demand and Strategic Upgrades Drive XOM's Refining Success — Positive
XOM Zacks Investment Research — December 31, 2025ExxonMobil's refining arm gains as cheaper crude, tight product supply and strategic refinery upgrades enable it to remain competitive.
Can Verizon's Fios and Fiber Push Deliver Strong Growth Impetus? — Positive
VZ Zacks Investment Research — December 31, 2025VZ ramps up fiber and 5G integration, aiming for faster broadband, expanded Fios reach and enhanced enterprise cloud and AI connectivity.
Pharma Stock Soars to Record Highs on FDA Buzz — Positive
AXSM Schaeffers Research — December 31, 2025Pharma stock Axsome Therapeutics Inc (NASDAQ:AXSM) is soaring to all-time highs, up 19% at $177.13 at last glance, after the U.S. Food & Drug Administration (FDA) granted priority review to AXS-05 -- its Alzheimer's disease agitation drug.
2026 a pivotal year for consumer internet and e-commerce, says Wedbush — Positive
AMZN Proactive Investors — December 31, 2025Wedbush Securities said 2026 is shaping up to be a decisive year for consumer internet companies, marked by a widening gap between winners and losers as investors assess artificial intelligence monetization, autonomous vehicle disruption, and sustained investment cycles across the sector. The firm wrote in a note that 2025 delivered solid performance for the group, with the analysts' coverage universe posting an average return of about 23%, compared with roughly 19% for the Nasdaq Index.
Is International Expansion the Key to Wolverine World Wide's Next Leg — Positive
WWW Zacks Investment Research — December 31, 2025WWW is leaning on international growth, with Saucony and Merrell fueling momentum across the APAC and EMEA markets.
KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic — Positive
KRMD Zacks Investment Research — December 31, 2025KORU Medical filed a 510(k) to use FreedomEDGE for subcutaneous PHESGO delivery, expanding into oncology and simplifying breast cancer care.
Sight Sciences: Improving Medicare Coverage Drives Eye-Popping Price Surge — Positive
SGHT Seeking Alpha — December 31, 2025Sight Sciences surged over 100% after two major Medicare contractors approved coverage for its TearCare dry eye treatment. Positive reimbursement decisions for TearCare open up a sizable market opportunity ($400 ASP and multiple millions of treatable patients) that was severely limited on a self-pay basis. OMNI is still the much larger business today, and while the company secured a positive reimbursement decision, market penetration may be limited or slowed by the company's tight finances.
CCL vs. NCLH: Which Cruise Stock Is Better Positioned for 2026? — Neutral
CCL NCLH Zacks Investment Research — December 31, 2025Carnival and Norwegian Cruise take different paths on growth, costs and leverage as investors weigh which operator looks better set for 2026.
What Falling Interest Rates Mean for KeyCorp's Net Interest Income — Negative
KEY Zacks Investment Research — December 31, 2025Falling rates may pressure margins, but KEY expects net interest income to grow as funding costs ease and loan volumes rise.
DUOL Bets on Teaching Quality and User Growth to Drive Long-Term Value — Positive
DUOL Zacks Investment Research — December 31, 2025Duolingo is pivoting toward long-term user growth and teaching quality, accepting near-term monetization uncertainty despite Q4 revenue and bookings guidance.
Robinhood and Coinbase battle it out for the prediction markets customer — Positive
COIN HOOD CNBC Television — December 31, 2025CNBC's MacKenzie Sigalos reports on the divergence in crypto-linked stocks: Robinhood is up more than 200% year to date while Coinbase is in the red, helped by Robinhood's early lead in one of the stickiest new products in brokerage apps — event contracts.
3 mREIT Stocks to Keep on Your Radar Amid Challenging Industry Trends — Positive
ARI EFC NREF Zacks Investment Research — December 31, 2025While the improving mortgage market trend is likely to support the Zacks REIT and Equity Trust industry, companies like ARI, EFC and NREF are poised to gain.
Can ARMN's Growth Investments Create Long-Term Value for Investors? — Positive
ARMN Zacks Investment Research — December 31, 2025Aris Mining is strengthening its growth pipeline with full ownership of Soto Norte and progress at Toroparu, backed by strong cash generation.
